1.Eyelid Reconstruction by the Semicircular Flap.
Journal of the Korean Ophthalmological Society 1991;32(9):709-714
Upper and lower eyelid defects of 40-60% can be reconstructed by the Tenzel semicircular flap technique. Lower eyelid defects of 75-80% can be successfully corrected if the lower eyelid retractors and inferior orbital septum are severed from their attachment. This technique provides several distinct advantages. It is useful for reconstruction of both the upper and lower eyelids. It can be accomplished without borrowing tissues from other sites. It provides a length about 1.5 times greater than would be available along the straight line diameter. The indications for the use of this procedure included basal cell carcinoma(4 cases), compound nevus(1 case), post-traumatic eyelid deformity(2 cases). We obtained cosmetically good results in all cases without any senous postoperative complications.
2.The Effect of Topical Interferon alpha-2b in the Treatment of Conjunctival Squamous Papilloma.
Journal of the Korean Ophthalmological Society 2006;47(11):1729-1734
PURPOSE: To study the effectiveness of Interferon alfa-2b (IFN alpha 2b) for treating squamous papilloma of the conjunctiva. METHODS: One million units/cc of IFN alpha 2b was applied 4 times a day after identifying squamous papilloma by excisional biopsy. The IFN alpha 2b was used continuously 2 to 6 months after the tumor became undetectable with the unaided eye. The dose was then tapered. RESULTS: Three of the 4 patients had a history of recurrences (1-4 times). In one patient, the tumor was difficult to remove surgically due to the location of the tumor (around the upper punctum). The tumor disappeared with no complications or recurrences during the follow-up period. CONCLUSIONS: In patients with conjunctival squamous papilloma with frequent relapses or difficulty in excision, applying IFN alpha 2b as an eye drop appears to be an effective form of therapy and can be used safely without complications.
Biopsy
;
Conjunctiva
;
Follow-Up Studies
;
Humans
;
Interferons*
;
Papilloma*
;
Recurrence
3.Management of Exposed Porous Orbital Implants.
Duck Young SUN ; Yoon Duck KIM
Journal of the Korean Ophthalmological Society 2004;45(9):1409-1419
PURPOSE: With its increasing popularity, several complications, such as infection, exposure, and extrusion have been reported in the use of the porous orbital implants. Exposure of the implants is one of the most difficult complications to treat. We evaluate the effect of treatment in exposed porous orbital implants with various techniques. METHODS: From January 1995 to December 2000, 15 patients visited our clinic with exposure of implant after porous orbital implantation. The following procedures were used to cover the implants: observation with delayed prosthesis fitting and posterior vaulting of the prosthesis, burring away the anterior surface of the hydroxyapatite implant and placing dermis fat graft, removing infected implants and dermis fat graft, and removal and 180degrees rotation and replacement of porous implants according to the degree of exposure. RESULTS: Porous implants exposures occurred 1 to 12 weeks after implantations (mean, 5.2 weeks). Small areas of exposure (<3mm) closed spontaneously (2 cases), remained stationary (2 cases), and increased the exposure area requiring dermis fat graft (1 case). During the follow-up period (mean, 19 months), no porous orbital implant was exposed again except 1 case who received previous orbital irradiation therapy. CONCLUSIONS: Small exposure of porous orbital implants less than 3 mm in diameter may be closed with nonsurgical methods. In the case of exposure larger than 4 mm, dermis fat graft or removal and 180degrees rotation and replacement of porous implants were effective in the treatment of exposure.
Dermis
;
Durapatite
;
Follow-Up Studies
;
Humans
;
Orbit*
;
Orbital Implants*
;
Prostheses and Implants
;
Prosthesis Fitting
;
Transplants
4.Radiation Therapy for Thyroid Orbitopathy.
Duck Young SUN ; Yoon Duck KIM
Journal of the Korean Ophthalmological Society 2003;44(1):1-9
PURPOSE: The aim of this study is to evaluate the effect of radiotherapy for the patients with Graves' orbitopathy who were intolerable to corticosteroid therapy. METHODS: From December 1995 to June 2000, We reviewed medical records of thirteen patients who had received orbital radiation delivering 2000 cGy in 10 fractions over 2 weeks. RESULTS: Compressive optic neuropathy was improved in 3 of 4 patients (75%), and soft tissue swelling was improved in eight of 9 patients (88%). Proptosis was reduced in 3 of 13 (30%) patients. However, diplopia and ocular motility responded poorly and was improved only in 2 of 10 (20%) patients. No adverse effects of radiotherapy occurred in any patient. Specifically there was no sign of radiation-induced injury to optic nerve, retina, or lens. CONCLUSIONS: Radiotherapy was successful in patients with acute Graves' orbitopathy especially who had compressive optic neuropathy or soft tissue swelling. This modality was useful for those who showed intolerable side effects from the use of corticosteroid or the recurrence with corticosteroid treatment.
Diplopia
;
Exophthalmos
;
Humans
;
Medical Records
;
Optic Nerve
;
Optic Nerve Diseases
;
Orbit
;
Radiotherapy
;
Recurrence
;
Retina
;
Thyroid Gland*
5.A Case of Angiommunoblastic Lymphadenopathy.
Moon Soo YOON ; Duck Hyun KIM ; Jong Hwa LEE
Korean Journal of Dermatology 1987;25(2):274-278
Herein we report a 51-year-old male with angioimmunoblastic lymphadenopathy who had developed rnaculopapular eruptions after the administration of crystalline penicillin, acetylsalicylic acid and sulpyrine. Skin biopsy showed mild lyrnphohistiocytic infiltration and extravasated RBCs around the blood vessels in the upper dermis. He had run a progressively downhill course in spite of vigorous chemotherapy and ultimately died.
Aspirin
;
Biopsy
;
Blood Vessels
;
Crystallins
;
Dermis
;
Dipyrone
;
Drug Therapy
;
Humans
;
Immunoblastic Lymphadenopathy
;
Lymphatic Diseases*
;
Male
;
Middle Aged
;
Penicillins
;
Skin
6.Two-year Follow-up after Visual Laser Ablation of Prostate (V-LAP) for BPH.
Jong Bo CHOI ; Dong Sun KIM ; Duck Ki YOON
Korean Journal of Urology 2000;41(12):1546-1550
No abstract available.
Follow-Up Studies*
;
Laser Therapy*
;
Prostate*
7.Surgical treatment of essential blepharospasm.
Korean Journal of Ophthalmology 1988;2(2):90-94
Essential blepharospasm is an incurable disease for which many treatment modalities fave been tried. The author has performed the Anderson's muscle stripping procrdure involving the meticulous extirpation of all eyelid protractors and reinrorcement or the retractors in three patients with essential blerharospasm withgratifying results.
Adult
;
Aged
;
Blepharospasm/*surgery
;
Eyelid Diseases/*surgery
;
Female
;
Humans
;
Middle Aged
;
Oculomotor Muscles/*surgery
8.A Case of Carcinoma Erysipelatoides Originating in an Internal Organ.
Moon Soo YOON ; Duck Hyun KIM ; Kyung Tai HONG
Korean Journal of Dermatology 1987;25(1):123-125
We present a case of carcinoma erysipelatoides which or iginated from an internal organ. The patient was a 50 year-old female who had peritoneal carcinomatosis, She presented an erythematous lesion resembling erysipelas on her right breast. Histopathologic findings were consistent with metastatic adenocarcinoma but clinically it was not associated with carcinoma of the breast.
Adenocarcinoma
;
Breast
;
Carcinoma
;
Erysipelas
;
Female
;
Humans
;
Middle Aged
9.The Surgical Treatment of Ptosis with Marcus-Gunn(Jaw-Winking) Phenomenon.
Journal of the Korean Ophthalmological Society 1993;34(9):900-906
The authors operated 7 cases with severe ptosis and moderate to severe jaw-winking phenomenon, with the extirpation of the levator muscle above Whitnall's ligament on affected eye and the bilateral frontalis suspension with preserved fascia lata. Seven patients observed for up to 22.5 months have had cosmetically and functionally desirable results with disappearance of jaw-winking phenomenon.
Fascia Lata
;
Humans
;
Ligaments
10.An Immunohistochemical Study of Vascular Endothelial Growth Factor as a Predictor of Progression in Bladder Cancer.
Jong Bo CHOI ; Dong Hee YOON ; Dong Sun KIM ; Duck Ki YOON ; Jae Heung CHO
Korean Journal of Urology 2000;41(7):807-811
No abstract available.
Urinary Bladder Neoplasms*
;
Urinary Bladder*
;
Vascular Endothelial Growth Factor A*